The University of Cincinnati Cancer Center's Eric Vick, MD, PhD, has been awarded a nearly $215,000 Career Development Award from the Leukemia and...
Vous n'êtes pas connecté
To help accelerate research into new treatments for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), Thermo Fisher Scientific Inc., the world leader in serving science, is partnering with the National Cancer Institute (NCI) – part of the National Institutes of Health – on the
The University of Cincinnati Cancer Center's Eric Vick, MD, PhD, has been awarded a nearly $215,000 Career Development Award from the Leukemia and...
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Thermo Fisher Scientific Inc. (TMO) and...
An internal review board at the National Institutes of Health has decided to shut down a long-term study of Havana Syndrome patients that found no...
Researchers at the Terasaki Institute for Biomedical Innovation have been awarded a multi-million grant from the National Institutes of Health (NIH)...
Researchers at the Terasaki Institute for Biomedical Innovation have been awarded a multi-million grant from the National Institutes of Health (NIH)...
Competitive: Parexel: If you want to be part of a leading CRO and transform scientific discoveries into new treatments, then Parexel FSP challenges...
A team led by research scientists from the Indiana University School of Medicine and Regenstrief Institute has received funding expected to total...
IQVIA: The IQVIA Research and Development Solutions team is focused on helping our healthcare customers to find innovative treatments solutions...
IQVIA: The IQVIA Research and Development Solutions team is focused on helping our healthcare customers to find innovative treatments solutions...
IQVIA: The IQVIA Research and Development Solutions team is focused on helping our healthcare customers to find innovative treatments solutions...